Otology Labs has developed a proprietary drug management platform called Otrix that enables the design of highly specialized broad class of molecules with leading ability to track compliance across all regulatory bodies internationally, our tool let's you continuously ensure your device or drug meets all necessary regulations and tracks for any changes automatically using AI.

We are advancing a broad and diverse pipeline of novel treatments to inner ear disease. These are medicines that are designed to prevent, or slow down the progression of some of the most common causes of hearing loss. Further increasing approaches offers surgeons more tools giving better patient care and long term outlook. Strategic uses of approved FDA drugs will minimize the time to market, partnerships with other leading companies and organizations are allowing us to expand the our pipeline and offer preventative medicine to diseases.